2022 Swedish procedure coding classification (KVÅ) released


Nov 2021

In November 2021, the National Board of Health and Welfare released an annual update of the Swedish procedure coding system (Classification of Health Care Measures, KVÅ) that will come into force in January 2022. KVÅ includes two parts – medical procedures (KMÅ) and surgical procedures (KKÅ) divided by chapters based on anatomical principles.

In 2022, six new surgical procedure codes will be introduced, five of which related to ECLS (extracorporeal life support) and ECMO (extracorporeal membrane oxygenation), and one code for bronchoscopy. Some examples are provided below:

  • FXF05 Peripheral percutaneous cannulation for extracorporeal life support (ECMO/ECLS);
  • FXF30 Combination of central and peripheral cannulation for extracorporeal life support (ECMO/ECLS);
  • UGC32 Bronchoscopy with electromagnetic navigation.

Furthermore, structural changes will be made in Chapter V "Operations on the aorta, peripheral vessels, and lymphatic system," which was introduced in 2021 (replaced Chapter P). It covers the entire artery tree from the aortic ascendant after the coronary arteries depart. In 2022, sub-chapter VK "Operations on the femoral artery and its branches" (122 codes) will be deleted and replaced by two new sub-chapters:

  • VL "Operations on infrapopliteal arteries as well as operations from the femoral and popliteal arteries to infrapopliteal arteries" with a total of 145 new codes;
  • VJ "Operations on the femoral and popliteal arteries as well as the AV graft and AV fistulas from the femoral artery" with a total of 173 new codes.

In 2022, a total of 53 new medical procedure codes (KMÅ) will be added concerning extracorporeal treatment, ENT, in-vitro diagnostics, neurology, orthopedic, and others. Some examples are provided below:

  • DD021 Upgrading of speech processor for a cochlear implant;
  • DV100 Treatment with extracorporeal carbon dioxide removal (ECCO2R);
  • DV101 Treatment with venovenous (VV) extracorporeal membrane oxygenation (ECMO);
  • AJ100 Triglyceride Exhalation Test. Note: used to diagnose exocrine pancreatic insufficiency, measuring the ability to cleave triglyceride enzymatically;
  • AN105 Fracture risk assessment based on clinical factors with or without FRAX.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news


Jun 2023

In the period of April-May 2023, the Galician Agency for Health Technology Assessment (AVALIA-T) initiated the five health technology assessments referred to IVD, nephrology and urology, obstetrics and gynecology, pulmonary and airways as well as surgical procedures technology groups. The assessments on stereotactic virtual navigation system for percutaneous puncture as well as tumor ablation and invasive telemonitoring of pulmonary pressure in patients with heart failure were released.

Read more


Jun 2023

In May 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries), two new Diagnostic Guidance (MRI fusion biopsy systems for diagnosing prostate cancer, automated ankle-brachial pressure index measurement devices to detect peripheral arterial disease), and three new Health Technology Evaluations (Digitally enabled therapies for adults with anxiety disorders / with depression, and point-of-care tests for urinary tract infections). Also, four clinical guidelines were updated.

Read more


May 2023

In April and May 2023, it was announced that the Galician Agency for Health Technology Assessment (AVALIA-T) initiated several HTAs, including the evaluations in the e-health, nephrology and urology, men’s health, IVD, obstetrics and gynecology, pulmonary and airways, surgical procedures, and some other fields.

Read more


May 2023

On April 28, 2023, the NHS Cancer Programme awarded £12.1 million to six innovations that improve the early detection and diagnosis of cancer. Awarded medical devices, in-vitro diagnostics, and digital health solutions are used to diagnose bowel, skin, liver, breast, ovarian, and esophageal cancer. They have proven their efficacy and clinical effectiveness and will be funded over the next 18 months to support rollout and real-world testing.

Read more


May 2023

In late April, NHS Accelerated Access Collaborative introduced the Health Technology Navigation Pathway Tool to help innovators adopt new technologies into the NHS. The Tool breaks the innovation journey down into 25 steps, themed around the five key phases of the product lifecycle, from creation to commissioning and adoption. For each step, the schematic flowchart outlines key organizations to engage with, regulatory insights, best practice approaches, policies, guidelines, to-do lists, and required outputs.

Read more